prednisone and Glycogen Storage Disease Type V
prednisone has been researched along with Glycogen Storage Disease Type V in 2 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jerusalem, F | 1 |
Higgs, JB | 1 |
Blaivas, M | 1 |
Albers, JW | 1 |
Reviews
1 review available for prednisone and Glycogen Storage Disease Type V
Article | Year |
---|---|
[Treatment of myopathies and spinal muscular atrophies (author's transl)].
Topics: Amyotrophic Lateral Sclerosis; Azathioprine; Collagen Diseases; Dermatomyositis; Glycogen Storage Di | 1978 |
Other Studies
1 other study available for prednisone and Glycogen Storage Disease Type V
Article | Year |
---|---|
McArdle's disease presenting as treatment resistant polymyositis.
Topics: Adult; Biopsy; Diagnosis, Differential; Drug Resistance; Exercise; Female; Glycogen Storage Disease | 1989 |